Literature DB >> 19592285

Systemic hypertension in two patients with ASL deficiency: a result of nitric oxide deficiency?

Nicola Brunetti-Pierri1, Ayelet Erez, Oleg Shchelochkov, William Craigen, Brendan Lee.   

Abstract

Argininosuccinic aciduria (ASA) is an inborn error of ureagenesis which if untreated leads to hyperammonemia, accumulation of argininosuccinic acid and arginine depletion. The presence of high blood pressure in patients with ASA has been reported so far as transient in one newborn. We describe the first two patients, one child and one young adult, with ASA and persistent systemic hypertension. Extensive evaluation of both patients excluded secondary causes of systemic hypertension. The intriguing link between nitric oxide (NO) production and hypertension lead us to hypothesize that the deficiency of endogenously synthesized arginine caused by ASL deficiency is responsible for the increased blood pressure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19592285      PMCID: PMC2746757          DOI: 10.1016/j.ymgme.2009.06.006

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  20 in total

1.  L-arginine infusion lowers blood pressure in children.

Authors:  L D Nelin; G M Hoffman
Journal:  J Pediatr       Date:  2001-11       Impact factor: 4.406

2.  Ambulatory blood pressure in schoolchildren.

Authors:  J J O'Sullivan; G Derrick; P Griggs; R Foxall; M Aitkin; C Wren
Journal:  Arch Dis Child       Date:  1999-06       Impact factor: 3.791

Review 3.  Ambulatory blood pressure measurements.

Authors:  J M Sorof; R J Portman
Journal:  Curr Opin Pediatr       Date:  2001-04       Impact factor: 2.856

4.  Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension.

Authors:  C W Belsha; T G Wells; K L McNiece; P M Seib; J K Plummer; P L Berry
Journal:  Am J Hypertens       Date:  1998-04       Impact factor: 2.689

5.  Neonatal pulmonary hypertension--urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function.

Authors:  D L Pearson; S Dawling; W F Walsh; J L Haines; B W Christman; A Bazyk; N Scott; M L Summar
Journal:  N Engl J Med       Date:  2001-06-14       Impact factor: 91.245

6.  Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents.

Authors: 
Journal:  Pediatrics       Date:  1996-10       Impact factor: 7.124

Review 7.  Nitric oxide and the liver.

Authors:  R Farzaneh-Far; K Moore
Journal:  Liver       Date:  2001-06

8.  Liver transplantation in urea cycle disorders.

Authors:  J M Saudubray; G Touati; P Delonlay; P Jouvet; C Narcy; J Laurent; D Rabier; P Kamoun; D Jan; Y Revillon
Journal:  Eur J Pediatr       Date:  1999-12       Impact factor: 3.183

9.  In vivo urea cycle flux distinguishes and correlates with phenotypic severity in disorders of the urea cycle.

Authors:  B Lee; H Yu; F Jahoor; W O'Brien; A L Beaudet; P Reeds
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

10.  Two cases suggesting a role for the L-arginine nitric oxide pathway in neonatal blood pressure regulation.

Authors:  C R Fakler; H A Kaftan; L D Nelin
Journal:  Acta Paediatr       Date:  1995-04       Impact factor: 2.299

View more
  19 in total

1.  Nitrite-NO bailout for a NOS complex too big to fail.

Authors:  Mark T Gladwin; Jesús Tejero
Journal:  Nat Med       Date:  2011-12-06       Impact factor: 53.440

Review 2.  Newborn screening and renal disease: where we have been; where we are now; where we are going.

Authors:  J Lawrence Merritt; David Askenazi; Si Houn Hahn
Journal:  Pediatr Nephrol       Date:  2011-09-27       Impact factor: 3.714

3.  Phase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: safety, pharmacokinetics and ammonia control.

Authors:  Brendan Lee; William Rhead; George A Diaz; Bruce F Scharschmidt; Asad Mian; Oleg Shchelochkov; J F Marier; Martin Beliveau; Joseph Mauney; Klara Dickinson; Antonia Martinez; Sharron Gargosky; Masoud Mokhtarani; Susan A Berry
Journal:  Mol Genet Metab       Date:  2010-03-23       Impact factor: 4.797

Review 4.  L-citrulline provides a novel strategy for treating chronic pulmonary hypertension in newborn infants.

Authors:  Candice D Fike; Marshall Summar; Judy L Aschner
Journal:  Acta Paediatr       Date:  2014-06-20       Impact factor: 2.299

5.  Chronic liver disease and impaired hepatic glycogen metabolism in argininosuccinate lyase deficiency.

Authors:  Lindsay C Burrage; Simran Madan; Xiaohui Li; Saima Ali; Mahmoud Mohammad; Bridget M Stroup; Ming-Ming Jiang; Racel Cela; Terry Bertin; Zixue Jin; Jian Dai; Danielle Guffey; Milton Finegold; Sandesh Nagamani; Charles G Minard; Juan Marini; Prakash Masand; Deborah Schady; Benjamin L Shneider; Daniel H Leung; Deeksha Bali; Brendan Lee
Journal:  JCI Insight       Date:  2020-02-27

6.  Requirement of argininosuccinate lyase for systemic nitric oxide production.

Authors:  Ayelet Erez; Sandesh C S Nagamani; Oleg A Shchelochkov; Muralidhar H Premkumar; Philippe M Campeau; Yuqing Chen; Harsha K Garg; Li Li; Asad Mian; Terry K Bertin; Jennifer O Black; Heng Zeng; Yaoping Tang; Anilkumar K Reddy; Marshall Summar; William E O'Brien; David G Harrison; William E Mitch; Juan C Marini; Judy L Aschner; Nathan S Bryan; Brendan Lee
Journal:  Nat Med       Date:  2011-11-13       Impact factor: 53.440

7.  Early orthotopic liver transplantation in urea cycle defects: follow up of a developmental outcome study.

Authors:  Philippe M Campeau; Penelope J Pivalizza; Geoffrey Miller; Kim McBride; Saul Karpen; John Goss; Brendan H Lee
Journal:  Mol Genet Metab       Date:  2010-02-19       Impact factor: 4.797

8.  Argininosuccinate Lyase Deficiency Causes an Endothelial-Dependent Form of Hypertension.

Authors:  Jordan Kho; Xiaoyu Tian; Wing-Tak Wong; Terry Bertin; Ming-Ming Jiang; Shan Chen; Zixue Jin; Oleg A Shchelochkov; Lindsay C Burrage; Anilkumar K Reddy; Hong Jiang; Reem Abo-Zahrah; Shuangtao Ma; Ping Zhang; Karl-Dimiter Bissig; Jean J Kim; Sridevi Devaraj; George G Rodney; Ayelet Erez; Nathan S Bryan; Sandesh C S Nagamani; Brendan H Lee
Journal:  Am J Hum Genet       Date:  2018-08-02       Impact factor: 11.025

Review 9.  Optimizing therapy for argininosuccinic aciduria.

Authors:  Sandesh C S Nagamani; Brendan Lee; Ayelet Erez
Journal:  Mol Genet Metab       Date:  2012-07-20       Impact factor: 4.797

10.  A randomized controlled trial to evaluate the effects of high-dose versus low-dose of arginine therapy on hepatic function tests in argininosuccinic aciduria.

Authors:  Sandesh C S Nagamani; Oleg A Shchelochkov; Mary A Mullins; Susan Carter; Brendan C Lanpher; Qin Sun; Soledad Kleppe; Ayelet Erez; E O'Brian Smith; Juan C Marini; Brendan Lee
Journal:  Mol Genet Metab       Date:  2012-09-17       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.